Drimva

Flagship Pioneering

Sr. Director, Clinical Operations

$213K–$280K

Somerville, MA USA +1 · Director · Full-time · Posted Sep 24, 2026

Location
Somerville, MA USA
Metaphore Biotechnologies, Inc.
Experience
10+ years of progressive clinical operations experience.
Education
BS/MS/PhD degree in a scientific, healthcare, or related discipline; an advanced degree is preferred.

About the job

Leads hands-on clinical operations planning and execution for Metaphore’s first-in-human program, with primary responsibility for Phase 1 readiness, global study start-up, and delivery.

What you'll do

  • Plan and execute early clinical studies, including study timelines, budgets, forecasts, risks, and operational documentation.
  • Select and oversee CROs, vendors, and clinical sites; manage study start-up and execution across the U.S., Europe, Australia, and other regions.
  • Establish fit-for-purpose clinical operations processes and ensure studies meet protocol, ICH-GCP, regulatory, quality, and inspection-readiness requirements.

What they ask for

  • 10+ years of progressive clinical operations experience in biotechnology or pharmaceutical industry.
  • Direct experience leading first-in-human or Phase 1 studies from operational planning through site activation and ongoing execution.
  • Experience managing study budgets, vendor contracts, scopes of work, change orders, timelines, and forecasts.
  • BS/MS/PhD in a scientific, healthcare, or related discipline; strong knowledge of ICH-GCP and FDA, EU, and other ex-U.S. clinical trial requirements.

Nice to have

  • Advanced degree; experience in both biotechnology and pharmaceutical company environments.
  • Early-phase study experience in Australia, China, antibody or biologic programs, or specialized biomarker and bioanalytical strategies.

Pay

$213,000 - $280,000 USD base salary

Tools

AI/ML, CROs, ICH-GCP, TMF, FDA, EU

AI focus

No AI-related job duties; the posting notes that applicant data may be reviewed using AI-assisted screening tools.

Model-written summary · the original posting is authoritative

First seen Oct 27, 2026 · Last verified Nov 6, 2026 (UTC)